Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis associated more strongly with arteriosclerosis and ischemic-appearing glomeruli in the superficial region.
|
31278193 |
2019 |
IGA Glomerulonephritis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Crescents and Global Glomerulosclerosis in Chinese IgA Nephropathy Patients: A Five-Year Follow-Up.
|
30808856 |
2019 |
Icterus
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months.
|
31664948 |
2019 |
Axonal neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This report provides further evidence that MPV17 mutations should be considered in patients with pure, non-syndromic axonal neuropathy.
|
30298599 |
2019 |
Myoclonic Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotypes & genotypes included Mitochondrial Encephalopathy Lactic Acidosis and Stroke like episodes (MELAS) & m.3243A>G mutation (n = 10), Myoclonic Epilepsy Ragged Red Fiber syndrome (MERRF) & m.8344A>G mutation (n = 4), Chronic Progressive External Ophthalmoplegia plus &POLG1 mutation (CPEO, n = 6), episodic neuroregression due to nuclear mutations (n = 6; NDUFV1 (n = 3), NDUFA1, NDUFS2, MPV17-1 one each), and one patient with infantile basal ganglia stroke syndrome, mineralizing angiopathy &MT-ND5 mutations.
|
29272804 |
2018 |
Myopathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement.
|
29282788 |
2018 |
Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement.
|
29282788 |
2018 |
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like episodes (MELAS syndrome)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotypes & genotypes included Mitochondrial Encephalopathy Lactic Acidosis and Stroke like episodes (MELAS) & m.3243A>G mutation (n = 10), Myoclonic Epilepsy Ragged Red Fiber syndrome (MERRF) & m.8344A>G mutation (n = 4), Chronic Progressive External Ophthalmoplegia plus &POLG1 mutation (CPEO, n = 6), episodic neuroregression due to nuclear mutations (n = 6; NDUFV1 (n = 3), NDUFA1, NDUFS2, MPV17-1 one each), and one patient with infantile basal ganglia stroke syndrome, mineralizing angiopathy &MT-ND5 mutations.
|
29272804 |
2018 |
Amyloidosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis was not correlated with adrenal morphology and neither kidney nor liver amyloidosis contributed significantly to variation in AW or ACMR on multivariate analyses.
|
28026881 |
2017 |
Arteriolar hyalinosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
DM was significantly associated with decrease in percent eGFR (p<0.05) and increase in arteriolar hyalinosis (p=0.004), Glomerulosclerosis (p=0.03) and Interstitial fibrosis/ Tubular atrophy (p=.0001).
|
28379664 |
2017 |
Arteriolosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis and arteriolosclerosis scores were significantly lower (p<0.001) in the RMR+CAA group when compared with the RMR group.
|
29032332 |
2017 |
Acute flaccid paralysis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
MPV17 hepatocerebral mitochondrial DNA depletion syndrome presenting as acute flaccid paralysis - A case report.
|
28673863 |
2017 |
Miller Dieker syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive mutations in MPV17 have been identified in the hepatocerebral form of MDS.
|
22824774 |
2013 |
MYELODYSPLASTIC SYNDROME
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Autosomal recessive mutations in MPV17 have been identified in the hepatocerebral form of MDS.
|
22824774 |
2013 |
Alpers Syndrome (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Defects in a group of nuclear genes involved in the maintenance of mtDNA integrity may also affect the white matter; for example, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) caused by thymidine phosphorylase deficiency, Navajo neurohepatopathy (NNH) due to MPV17 mutations, and Alpers syndrome due to defects in DNA polymerase gamma (POLG).
|
22422207 |
2012 |
Leukoencephalopathy
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Here we show that mutation of MPV17 - a gene implicated in severe, infantile hepatocerebral mtDNA depletion disorders characterised by a loss of mtDNA copies - can also cause clonally-expanded mtDNA deletion and focal cytochrome c oxidase (COX) deficiency in skeletal muscle associated with an adult presentation of neuropathy and leukoencephalopathy.
|
22508010 |
2012 |
Neuropathy
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Here we show that mutation of MPV17 - a gene implicated in severe, infantile hepatocerebral mtDNA depletion disorders characterised by a loss of mtDNA copies - can also cause clonally-expanded mtDNA deletion and focal cytochrome c oxidase (COX) deficiency in skeletal muscle associated with an adult presentation of neuropathy and leukoencephalopathy.
|
22508010 |
2012 |
Encephalopathies
|
0.010 |
Biomarker
|
group |
BEFREE |
MPV17 is one of the genes causing combined encephalopathy and liver failure and at present there is no treatment for this devastating disease.
|
20614188 |
2010 |
Neurologic Symptoms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Mutations in the MPV17 gene have been reported in patients who came to medical attention during infancy with liver failure, hypoglycemia, failure-to-thrive and neurological symptoms.
|
20074988 |
2010 |
Liver Cirrhosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In spite of severe mtDNA depletion, only moderate decrease in respiratory chain enzymatic activities, and mild cytoarchitectural alterations, were observed in the Mpv17(-/-) livers, but neither cirrhosis nor failure ever occurred in this organ at any age.
|
18818194 |
2009 |
Leukodystrophy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We report on the clinical, biochemical and molecular findings of a patient presenting with lethal hepatopathy, polyneuropathy, neurological regression and leukodystrophy associated with mutations in MPV17.
|
18329934 |
2008 |
Polyneuropathy
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
We report on the clinical, biochemical and molecular findings of a patient presenting with lethal hepatopathy, polyneuropathy, neurological regression and leukodystrophy associated with mutations in MPV17.
|
18329934 |
2008 |
Mitochondrial Myopathies
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The most recently described mitochondrial myopathies are due to defects in nuclear DNA, including coenzyme Q10 deficiency and mutations in genes controlling mitochondrial DNA abundance and structure, such as POLG, TK2, and MPV17.
|
17053512 |
2006 |
COENZYME Q10 DEFICIENCY
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The most recently described mitochondrial myopathies are due to defects in nuclear DNA, including coenzyme Q10 deficiency and mutations in genes controlling mitochondrial DNA abundance and structure, such as POLG, TK2, and MPV17.
|
17053512 |
2006 |
Kidney Failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
YLR251W has significant homology to the mammalian peroxisomal membrane protein Mpv17, and Mpv17(-/-) mice exhibit age-onset glomerulosclerosis, deafness, hypertension, and, ultimately, death by renal failure.
|
15189984 |
2004 |